维普中文期刊产品整合服务
87篇 您的检索式:作者名="Zanaboni"
    题名 作者 年代 出处 被引量
1Performance of liver stiffness measurements by transient elastography in chronic hepatitis显示文摘AIM:To compare results of liver stiffness measurements by transient elastography(TE) obtained in our patients population with that used in a recently published meta-analysis.METHODS:This was a single center cross-sectional study.Consecutive patients with chronic viral hepatitis scheduled for liver biopsy at the outpatient ward of our Infectious Diseases Department were enrolled.TE was carried out by using FibroScan(Echosens,Paris,France).Liver biopsy was performed on the same day as TE,as day case procedure.Fibrosis was staged according to the Metavir scoring system.The diagnostic performance of TE was assessed by using receiver operating characteristic(ROC) curves and the area under the ROC curve analysis.RESULTS:Two hundred and fifty-two patients met the inclusion criteria.Six(2%) patients were excluded due to unreliable TE measurements.Thus,246(171 men and 75 women) patients were analyzed.One hundred and ninety-five(79.3%) patients had chronic hepatitis C,41(16.7%) had chronic hepatitis B,and 10(4.0%) were coinfected with human immunodeficiency virus.ROC curve analysis identified optimal cut-off value of TE as high as 6.9 kPa forF ≥ 2;7.9 kPa forF ≥ 3;9.6 kPa for F = 4 in all patients(n = 246),and as high as 6.9 kPa for F ≥ 2;7.3 kPa for F ≥ 3;9.3 kPa for F = 4 in patients with hepatitis C(n = 195).Cut-off values of TE obtained by maximizing only the specificity were as high as 6.9 kPa for F ≥ 2;9.6 kPa for F ≥ 3;12.2 kPa for F = 4 in all patients(n = 246),and as high as 7.0 kPa forF ≥ 2;9.3 kPa forF ≥ 3;12.3 kPa forF = 4 in patients with hepatitis C(n = 195).CONCLUSION:The cut-off values of TE obtained in this single center study are comparable to that obtained in a recently published meta-analysis that included up to 40 studies.Giovanna Ferraioli Carmine Tinelli Barbara Dal Bello Mabel Zicchetti Raffaella Lissandrin Gaetano Filice Carlo Filice Elisabetta Above Giorgio Barbarini Enrico Brunetti Willy Calderon Marta Di Gregorio Roberto Gulminetti Paolo Lanzarini Serena Ludovisi Laura Maiocchi Antonello Malfitano Giuseppe Michelone Lorenzo Minoli Mario Mondelli Stefano Novati Savino FA Patruno Alessandro Perretti Gianluigi Poma Paolo Sacchi Domenico Zanaboni Marco Zaramella 2013World Journal of Gastroenterology2013,19,1:18
2Nerve-sparing radical hysterectomy: a surgical technique for preserving the autonomic hypogastric nerve显示文摘Francesco Raspagliesi Antonino Ditto Rosanna Fontanelli Eugenio Solima Francesco Hanozet Flavia Zanaboni Shigeki Kusamura 2004Gynecologic Oncology2004,,2:2
3Percutaneous and surgical treatment of pyogenic liver abscesses:observation over a 21-year period in 148 patients显示文摘Ferraioli G Garlaschelli A Zanaboni D 2008Dig Liver Dis2008,40,8:1
4Physiologic effects of positive end-expiratory pressure and mask pressure support during exacerbations of chronic obstructive pulmonary disease显示文摘Appendini L Potassio A Zanaboni S 1994Am J Respir Crit Care Med1994,149,5:1
5Physiologic effects of positive end - expiratory pressure and mask pressure support during exacerbations of chronic obstructive pulmonary disease显示文摘Appendini L Patessio A Zanaboni S 1994Am J Respir Crit Care Med1994,149,5:1
6Percutaneous and surgical treatment of pyogenic liver abscesses: observation over a 21 -year period in 148 patients显示文摘FERRAIOLI G GARLASCHELLI A ZANABONI D 2008Dig Liver Dis2008,40,8:1
7Percutaneous and surgical treatment of pyogenic liver abscesses:observation over a 21-year period in 148 patients显示文摘Ferraioli G Garlaschelli A Zanaboni D 2008Dig Liver Dis2008,40,8:1
8显示文摘Appendini L Potassio A Zanaboni S 1994Am J Respir Crit Care Med1994,149,:1
9Stratifying risk fac- tors for multidrug-resistant pathogens in hospitalized patients com- ing from the community with pneumonia显示文摘Aliberti S Di Pasquale M Zanaboni AM 2012Clin Infect Dis2012,54,4:1
10Percutaneous and surgical treatment of pyogenie liver abscesses: Observation over a 21-year period in 148 patients显示文摘Ferraioli G Garlaschelli A Zanaboni D 2008Digestive and Liver Disease2008,40,8:1
11Percutaneous and sur- gical treatment of pyogenic liver abscesses: observation over a 21- year period in 148 patients显示文摘Ferraioli G Garlaschelli A Zanaboni D 2008Dig Liver Dis2008,40,8:1
12Adoption of telemedicine: from pilot stage to routine delivery显示文摘Zanaboni P Wootton R 2012BMC medical informatics and decision making2012,12,1:1
13Assessment of a remote monitoring system for implantable cardioverter defibrillators 显示文摘Masella C Zanaboni P Di Stasi F 2008J Telemed Teleeare2008,14,6:1
14Waist-to-height ratio is a highly sensitive index for the metabolic syndrome in a Mediterranean population显示文摘Mombelli G Zanaboni AM Gaito S 2009Metab Syndr Relat Disord2009,7,5:1
15Intensive care for pediatric traumatic brain injury显示文摘Sigurtà A Zanaboni C Canavesi K 0,,01:1
16Stratifying risk factors for multidrug - resistant pathogens in hospitalized patients coming from the community with pneumonia 显示文摘Aliberti S Di Pasquale M Zanaboni AM 2012Clin Infect Dis2012,54,4:1
17Randomised trial of drains versus no drains following radical hyserectomy and pelviclymph node dissection:a European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group(eortc-gcg) study in 234 patients显示文摘Franchi M Trimbos JB Zanaboni F 2007Eur J Cancer2007,43,8:1
18Randomised trial of drains versus no drains following radical hysterectomy and pelvic lymph node dissection: a European Organisation for Research and Treatment of Cancer-Gynaecological Cancer Group (EORTG-43CG) study in 234 patients显示文摘Franchi M Trimbos J'B Zanaboni F 2007Eur J Cancer2007,43,8:1
19Gemcitabine combined with oxaliplatin (GEMOX) as second-line chemotherapy in patients with advanced ovarian cancer refractory or resistant to platinum and taxane显示文摘Raspagliesi F Zanaboni F Vecchione F 2004Oncology2004,67,56:1
20Stratifying riskfactors for multidrug-resistant pathogens in hospitalized patientscoming from the community with pneumonia 显示文摘Aliberti S Di Pasquale M Zanaboni AM etal 2012Clin InfectDis2012,54,4:1
返回顶部 每页显示:
共5页 首页 上一页 第1页 下一页 末页 /5 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费